arrow
B

Birgit Grund

University of Minnesota
H指数:25
被引数:2,904

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial

恩塞特雷韦治疗住院成人COVID-19:一项国际多中心III期随机安慰剂对照试验

2026-04-220
PRE
Effect of Delayed Antiretroviral Therapy Initiation on Anti-CD4 Autoantibodies in Antiretroviral Therapy-Naïve People With HIV

延迟抗逆转录病毒疗法启动对未接受抗逆转录病毒疗法的人类免疫缺陷病毒感染者中抗CD4自身抗体的影响

2026-01-010
PRE
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

针对COVID-19的STRIVE Ensitrelvir试验中在线药物相互作用筛查器的实施

2025-07-010
OAAI
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

中和单克隆抗体治疗对新型冠状病毒肺炎住院患者病毒学和免疫学生物标志物早期轨迹的影响

2023-11-091
OAAI
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023-09-017
OAAI
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase atrial
2022-10-0166
OAAI
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery

评估新型冠状病毒肺炎治疗试验的主要终点以评估恢复情况

2022-09-157
OAAI
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

在CD4 T细胞计数大于500的成人中,立即抗逆转录病毒治疗没有神经认知优势

AIDS
IF3.1
2018-05-1520
OAAI
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia

两种疫苗在利比里亚预防埃博拉的2期安慰剂对照试验

2017-10-12200
OAAI
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial
2017-06-2646
OAAI